EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

E. Le Rhun (1, 2, 3) , M. Weller (4) , D. Brandsma (5) , M. van den Bent (6) , E. de Azambuja (7) , R. Henriksson (8, 9) , T. Boulanger (2) , S. Peters (10) , C. Watts (11) , W. Wick (12, 13) , P. Wesseling (14, 15) , R. Rudà (16) , M. Preusser (17)

1 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
2 UNICANCER/Lille - Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille]
3 PRISM - Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U 1192
4 University hospital of Zurich [Zurich]
5 NKI - Netherlands Cancer Institute
6 Erasmus MC - Erasmus University Medical Center [Rotterdam]
7 Institut Jules Bordet [Bruxelles]
8 Regional Cancer Center Stockholm Gotland [Stockholm, Sweden]
9 Umeå University, Sweden
10 UNIL - Université de Lausanne = University of Lausanne
11 CAM - University of Cambridge [UK]
12 Heidelberg University Hospital [Heidelberg]
13 DKTK - German Cancer Consortium [Heidelberg]
14 VU University Medical Center [Amsterdam]
15 University Medical Center [Utrecht]
16 City of Health and Science University Hospital [Turin, Italy]
17 Medizinische Universität Wien = Medical University of Vienna

No abstract available

Domains: Life Sciences [q-bio]

E. Le Rhun, M. Weller, D. Brandsma, M. van den Bent, E. de Azambuja, et al.. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Annals of Oncology, 2017, 28, pp.iv84-iv99. ⟨10.1093/annonc/mdx221⟩. ⟨inserm-02940542⟩